UBS AM
BDSI

UBS AM’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

UBS AM’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-91,129
Closed -$283K – 2858
2021
Q4 		$283K Hold
91,129
– – ﹤0.01% 2692
2021
Q3 		$329K Hold
91,129
– – ﹤0.01% 2602
2021
Q2 		$326K Sell
91,129
-14,171
-13% -$50K ﹤0.01% 2635
2021
Q1 		$412K Hold
105,300
– – ﹤0.01% 2442
2020
Q4 		$442K Hold
105,300
– – ﹤0.01% 2331
2020
Q3 		$393K Hold
105,300
– – ﹤0.01% 2232
2020
Q2 		$459K Sell
105,300
-30,250
-22% -$136K ﹤0.01% 2158
2020
Q1 		$514K Buy
135,550
+53,103
+64% +$261K ﹤0.01% 1971
2019
Q4 		$521K Buy
+82,447
New +$485K ﹤0.01% 2218
2016
Q2 		– Sell
-28,300
Closed -$91K – 2684
2016
Q1 		$91K Sell
28,300
-3,400
-11% -$12.6K ﹤0.01% 2579
2015
Q4 		$152K Hold
31,700
– – ﹤0.01% 2601
2015
Q3 		$176K Hold
31,700
– – ﹤0.01% 2523
2015
Q2 		$252K Buy
31,700
+13,300
+72% +$114K ﹤0.01% 2469
2015
Q1 		$193K Buy
18,400
+1,000
+6% +$13.7K ﹤0.01% 2496
2014
Q4 		$209K Buy
+17,400
New +$264K ﹤0.01% 2453

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

UBS AM's BDSI Position: Q1 2022 in Review

UBS AM sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 91,129 shares — an estimated $283K sold.

UBS AM first reported a position in BDSI in Q4 2014 and held it in 15 quarters. The position peaked at $521K in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • UBS AM reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • UBS AM sold 91,129 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $283K.
  • UBS AM first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 15 quarters.
  • UBS AM's BioDelivery Sciences International, Inc. position peaked at $521K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.